Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular Mortality
Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular Mortality
Oncology Times Broadcast NewsSwedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascul... Read more
6 Oct 2009
•
4mins
Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue!
Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue!
Oncology Times Broadcast NewsAromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Bre... Read more
6 Oct 2009
•
6mins
Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome
Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome
John Burn talking at ECCO15-ESMO34 in Berlin about his international study showing that aspirin prevented the developmen... Read more
28 Sep 2009
•
7mins
For Early Breast Cancer, Switch to Aromatase Inhibitor after Tamoxifen Extends Survival
For Early Breast Cancer, Switch to Aromatase Inhibitor after Tamoxifen Extends Survival
Oncology Times Broadcast NewsFor Early Breast Cancer, Switch to Aromatase Inhibitor after Tamoxifen Extends SurvivalChar... Read more
28 Sep 2009
•
6mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For Early Colon Cancer
Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For Early Colon Cancer
Oncology Times Broadcast News: Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For Early Colon Ca... Read more
28 Sep 2009
•
9mins
"Promising Activity" Of Cetuximab In Patients With Advanced Biliary Cancer
"Promising Activity" Of Cetuximab In Patients With Advanced Biliary Cancer
BARCELONA, SPAIN—Adding cetuximab to gemcitabine/oxaliplatin (GEMOX) chemotherapy controlled disease among two thirds of... Read more
28 Sep 2009
•
2mins
Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos
Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos
Oncology Times Broadcast News: Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab... Read more
28 Sep 2009
•
6mins
Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Progression Free Survival
Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Progression Free Survival
Oncology Times Broadcast News: Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Progression Free... Read more
28 Sep 2009
•
4mins
Colorectal Cancer: KRAS-Driven Selection Of Molecular Therapy Could Save Millions: Bevacizumab, Cetuximab, Panitumomab, or Combinations?
Colorectal Cancer: KRAS-Driven Selection Of Molecular Therapy Could Save Millions: Bevacizumab, Cetuximab, Panitumomab, or Combinations?
11th Annual Palm Beach Cancer Symposium (April 3-4, 2009 Hollywood, Florida)—Peter Goodwin interviews John Macdonald, Ch... Read more
28 Sep 2009
•
3mins
Chronic Myeloid Leukemia 'To Become A Very Indolent Disease': Pregnancy Possible, Transplants Avoided—Mission Accomplished?
Chronic Myeloid Leukemia 'To Become A Very Indolent Disease': Pregnancy Possible, Transplants Avoided—Mission Accomplished?
11th Annual Palm Beach Cancer Symposium (April 3-4, 2009 Hollywood, Florida)—Peter Goodwin interviews Hagop Kantarjian M... Read more
28 Sep 2009
•
9mins
